Patient Acceptance of Sustained Glaucoma Treatment Strategies

Varshini Varadaraj, Malik Y. Kahook, Pradeep Ramulu, Ian Pitha

Research output: Contribution to journalArticle

Abstract

Purpose: To assess patient acceptance of different methods for delivering sustained-release, intraocular pressure (IOP)-lowering medications. Methods: Electronic surveys were administered to 150 patients at 2 glaucoma clinics. Participants were questioned on their willingness to accept: (1) drug-eluting contact lenses, (2) ring inserts (3) punctal plugs, and (4) subconjunctival injections as alternatives to IOP-lowering eye drops based on various success levels. Multivariable logistic regression models determined the association between device type and treatment acceptance adjusting for age, sex, study site, cost burden of drops, and previous contact lens use. Results: The majority (69%) of participants were 55 to 74 years of age, and white (65%), and half were female. The majority of participants would accept contacts (59%), rings (51%), plugs (57%), and subconjunctival injections (52%) if they obviated glaucoma surgery; fewer would accept these devices if they reduced (23% to 35%) or eliminated (27% to 42%) drops. Most participants would also accept contacts (56%), plugs (55%), and subconjunctival injections (53%) if they were more effective than eye drops, whereas only 47% would accept a ring; fewer would accept any device if it were equally or less effective than drops. Participants were also 36% (95% confidence interval=0.44-0.92; P=0.02) less likely to accept rings and 32% (95% confidence interval=0.47-0.98; P=0.04) less likely to accept subconjunctival injections as compared with contacts. Conclusion: Most glaucoma patients considered sustained drug-delivery modalities acceptable alternatives to IOP-lowering eye drops, but only when they were said to obviate surgery or demonstrate greater efficacy than eye drops.

Original languageEnglish (US)
Pages (from-to)328-335
Number of pages8
JournalJournal of Glaucoma
Volume27
Issue number4
DOIs
StatePublished - Jan 1 2018

Fingerprint

Ophthalmic Solutions
Glaucoma
Intraocular Pressure
Injections
Contact Lenses
Equipment and Supplies
Logistic Models
Confidence Intervals
Therapeutics
Pharmaceutical Preparations
Costs and Cost Analysis

Keywords

  • controlled release
  • drug-delivery systems
  • IOP reduction
  • ocular insert
  • patient acceptance of health care

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Patient Acceptance of Sustained Glaucoma Treatment Strategies. / Varadaraj, Varshini; Kahook, Malik Y.; Ramulu, Pradeep; Pitha, Ian.

In: Journal of Glaucoma, Vol. 27, No. 4, 01.01.2018, p. 328-335.

Research output: Contribution to journalArticle

Varadaraj, Varshini ; Kahook, Malik Y. ; Ramulu, Pradeep ; Pitha, Ian. / Patient Acceptance of Sustained Glaucoma Treatment Strategies. In: Journal of Glaucoma. 2018 ; Vol. 27, No. 4. pp. 328-335.
@article{bdbfa90a8ee84435ad7fc9438a80a5c1,
title = "Patient Acceptance of Sustained Glaucoma Treatment Strategies",
abstract = "Purpose: To assess patient acceptance of different methods for delivering sustained-release, intraocular pressure (IOP)-lowering medications. Methods: Electronic surveys were administered to 150 patients at 2 glaucoma clinics. Participants were questioned on their willingness to accept: (1) drug-eluting contact lenses, (2) ring inserts (3) punctal plugs, and (4) subconjunctival injections as alternatives to IOP-lowering eye drops based on various success levels. Multivariable logistic regression models determined the association between device type and treatment acceptance adjusting for age, sex, study site, cost burden of drops, and previous contact lens use. Results: The majority (69{\%}) of participants were 55 to 74 years of age, and white (65{\%}), and half were female. The majority of participants would accept contacts (59{\%}), rings (51{\%}), plugs (57{\%}), and subconjunctival injections (52{\%}) if they obviated glaucoma surgery; fewer would accept these devices if they reduced (23{\%} to 35{\%}) or eliminated (27{\%} to 42{\%}) drops. Most participants would also accept contacts (56{\%}), plugs (55{\%}), and subconjunctival injections (53{\%}) if they were more effective than eye drops, whereas only 47{\%} would accept a ring; fewer would accept any device if it were equally or less effective than drops. Participants were also 36{\%} (95{\%} confidence interval=0.44-0.92; P=0.02) less likely to accept rings and 32{\%} (95{\%} confidence interval=0.47-0.98; P=0.04) less likely to accept subconjunctival injections as compared with contacts. Conclusion: Most glaucoma patients considered sustained drug-delivery modalities acceptable alternatives to IOP-lowering eye drops, but only when they were said to obviate surgery or demonstrate greater efficacy than eye drops.",
keywords = "controlled release, drug-delivery systems, IOP reduction, ocular insert, patient acceptance of health care",
author = "Varshini Varadaraj and Kahook, {Malik Y.} and Pradeep Ramulu and Ian Pitha",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/IJG.0000000000000913",
language = "English (US)",
volume = "27",
pages = "328--335",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Patient Acceptance of Sustained Glaucoma Treatment Strategies

AU - Varadaraj, Varshini

AU - Kahook, Malik Y.

AU - Ramulu, Pradeep

AU - Pitha, Ian

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: To assess patient acceptance of different methods for delivering sustained-release, intraocular pressure (IOP)-lowering medications. Methods: Electronic surveys were administered to 150 patients at 2 glaucoma clinics. Participants were questioned on their willingness to accept: (1) drug-eluting contact lenses, (2) ring inserts (3) punctal plugs, and (4) subconjunctival injections as alternatives to IOP-lowering eye drops based on various success levels. Multivariable logistic regression models determined the association between device type and treatment acceptance adjusting for age, sex, study site, cost burden of drops, and previous contact lens use. Results: The majority (69%) of participants were 55 to 74 years of age, and white (65%), and half were female. The majority of participants would accept contacts (59%), rings (51%), plugs (57%), and subconjunctival injections (52%) if they obviated glaucoma surgery; fewer would accept these devices if they reduced (23% to 35%) or eliminated (27% to 42%) drops. Most participants would also accept contacts (56%), plugs (55%), and subconjunctival injections (53%) if they were more effective than eye drops, whereas only 47% would accept a ring; fewer would accept any device if it were equally or less effective than drops. Participants were also 36% (95% confidence interval=0.44-0.92; P=0.02) less likely to accept rings and 32% (95% confidence interval=0.47-0.98; P=0.04) less likely to accept subconjunctival injections as compared with contacts. Conclusion: Most glaucoma patients considered sustained drug-delivery modalities acceptable alternatives to IOP-lowering eye drops, but only when they were said to obviate surgery or demonstrate greater efficacy than eye drops.

AB - Purpose: To assess patient acceptance of different methods for delivering sustained-release, intraocular pressure (IOP)-lowering medications. Methods: Electronic surveys were administered to 150 patients at 2 glaucoma clinics. Participants were questioned on their willingness to accept: (1) drug-eluting contact lenses, (2) ring inserts (3) punctal plugs, and (4) subconjunctival injections as alternatives to IOP-lowering eye drops based on various success levels. Multivariable logistic regression models determined the association between device type and treatment acceptance adjusting for age, sex, study site, cost burden of drops, and previous contact lens use. Results: The majority (69%) of participants were 55 to 74 years of age, and white (65%), and half were female. The majority of participants would accept contacts (59%), rings (51%), plugs (57%), and subconjunctival injections (52%) if they obviated glaucoma surgery; fewer would accept these devices if they reduced (23% to 35%) or eliminated (27% to 42%) drops. Most participants would also accept contacts (56%), plugs (55%), and subconjunctival injections (53%) if they were more effective than eye drops, whereas only 47% would accept a ring; fewer would accept any device if it were equally or less effective than drops. Participants were also 36% (95% confidence interval=0.44-0.92; P=0.02) less likely to accept rings and 32% (95% confidence interval=0.47-0.98; P=0.04) less likely to accept subconjunctival injections as compared with contacts. Conclusion: Most glaucoma patients considered sustained drug-delivery modalities acceptable alternatives to IOP-lowering eye drops, but only when they were said to obviate surgery or demonstrate greater efficacy than eye drops.

KW - controlled release

KW - drug-delivery systems

KW - IOP reduction

KW - ocular insert

KW - patient acceptance of health care

UR - http://www.scopus.com/inward/record.url?scp=85045072808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045072808&partnerID=8YFLogxK

U2 - 10.1097/IJG.0000000000000913

DO - 10.1097/IJG.0000000000000913

M3 - Article

C2 - 29462013

AN - SCOPUS:85045072808

VL - 27

SP - 328

EP - 335

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

IS - 4

ER -